Pharmaceutical companies think inversions are good for their health The success of two pharmaceutical companies to close in on these taxbeneficial deals on Monday marked the latest wins in the healthcare industrys efforts to head overseas for tax purposes Several US drug companies have been trying to buy foreign rivals in
  